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In the last 30 years we have assisted to a massive advance of nanomaterials in material
science. Nanomaterials and structures, in addition to their small size, have properties
that differ from those of larger bulk materials, making them ideal for a host of novel
applications. The spread of nanotechnology in the last years has been due to the
improvement of synthesis and characterization methods on the nanoscale, a field rich
in new physical phenomena and synthetic opportunities. In fact, the development of
functional nanoparticles has progressed exponentially over the past two decades. This
work aims to extensively review 30 years of different strategies of surface modification
and functionalization of noble metal (gold) nanoparticles, magnetic nanocrystals and
semiconductor nanoparticles, such as quantum dots. The aim of this review is not only
to provide in-depth insights into the different biofunctionalization and characterization
methods, but also to give an overview of possibilities and limitations of the available
nanoparticles.
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INTRODUCTION
Every object with at least one characteristic dimension between
1 and 100 nm can be defined as “nanomaterial.” The importance
of nanomaterials (e.g. nanoparticles, NPs) for science and tech-
nology has highly increased in the last years (Surendiran et al.,
2009). When dealing with such a small structure, the size-related
properties, the shape and inter-particle distance to the core, the
charge, the dielectric properties of the conjugated system (includ-
ing refractive index and polarizability), the dielectric medium
surrounding the particle (solvent) and the composition moieties
are extremely important and may sturdily influence the physi-
cal and chemical characteristics of the nanomaterials. This means
that these distinct properties, such as quantum confinement in
semiconductor nanocrystals or surface plasmon resonance (SPR)
in somemetal NPs, may influence physical and chemical behavior
of nanomaterials (Bellucci, 2009; Doria et al., 2012).
The unbelievable development of nanotechnology in the last
30 years has allowed the release of new and efficient synthetic
routes toward the production and functionalization of differ-
ent NPs, composed of a variety of materials including noble
metals [e.g. gold and silver (Conde et al., 2012c; Doria et al.,
2012; Dreaden et al., 2012)], semiconductors [e.g. CdSe and CdTe
(Murray et al., 1993), TiO2 (Sudhagar et al., 2012), InP (Xu et al.,
2006)], magnetic compounds (Pankhurst et al., 2003), and their
combinations, such as core–shell (Cao et al., 2001) and alloy NPs
(Doria et al., 2010).
The unique characteristics of these NPs, such as high
surface-to-volume ratio or size-dependent optical and magnetic
properties, are drastically different from those of their bulk mate-
rials and hold pledge in the clinical field (Kim, 2007; Heath
and Davis, 2008). Technological advances in nanoparticle syn-
thesis/functionalization are producing significant advances in
molecular detection and imaging, target and multifunctional
therapeutics and in prevention/control of diseases. Through
the development of new imaging agents, novel multifunctional
targeted devices capable of overcoming biological barriers for
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direct delivery of therapeutic agents to diseased cells and tis-
sues, and innovative monitoring sensors for predictive molecular
changes, increase the processes’ efficiency while minimizing costs
(Baptista, 2009; Minelli et al., 2010; Ma et al., 2011; Conde et al.,
2012c). Besides being an area of intense upfront basic research,
nanotechnology holds the key to future technological applica-
tions. It is a burgeoning field as more and improved techniques
are becoming available for clinical therapy and diagnostics with
increased sensitivity and efficiency at lower costs (Baptista et al.,
2008; Lammers et al., 2011).
In spite of these advantages, NPs do have limitations. For
example, their small size and large surface area can lead to
particle-particle aggregation and may result in limited loading of
functional components and burst release. In fact, only NPs with
the appropriate size and surface chemistry are not immediately
recognized by the immune system and show increased circulation
times (Gil and Parak, 2008; Shvedova et al., 2010). Nevertheless,
their unique and broad-based optical properties, their ease of
synthesis and facile surface chemistry and, most importantly,
their appropriate size scale are overcoming these drawbacks and
have been generating much eagerness in clinical diagnostics and
therapy (Sperling et al., 2008).
Here we will review different strategies of biofunctionalization
and characterization methods of inorganic nanoparticles, as well
as their main advantages and limitations. Our aim is to discuss the
challenges of working with nanoparticles while giving an overall
overview of the state-of-the-art.
INORGANIC NANOPARTICLES
GOLD NANOPARTICLES
Historically, colloidal gold has been used since ancient times
mainly as a method for glass staining. However, it was not until
Faraday’s work that gold nanoparticles (AuNPs) began to be stud-
ied in a scientific approach (Faraday, 1857). Since then, AuNPs
have generated ever-increasing interest and in the last few decades
more and more controllable synthesis methods and applications
in diverse nanosystems have been developed (Wagner et al., 2000;
Edwards and Thomas, 2007).
AuNPs, also known as colloidal gold, are a suspension of
sub-micrometer-sized gold metal particle in a fluid and can be
obtained with diameters between 3 and 200 nm. AuNPs have
gained increasing interest due to their special features, such as
extraordinary optical and electronic properties, high stability and
biological compatibility, controllable morphology and size dis-
persion, and easy surface functionalization (Sperling et al., 2008).
The optical properties of AuNPs are significant because
absorption and emission are within the visible range of light (El-
Sayed, 2001). Of particular interest is the light extinction process
in the UV-visible range, which occurs when an electromagnetic
wave passes through a metal particle exciting its electronic or
vibrational states (Kreibig and Vollmer, 1995). This phenomenon
induces dipole moments that oscillate at the respective frequency
of the incident wave, dispersing secondary radiation in all direc-
tions. This collective oscillation of the free conduction electrons
is called localized surface plasmon resonance (LSPR). The SPR is
the collective oscillation of the electrons in the conduction band.
The oscillation frequency is usually in the visible region giving
rise to the strong SPR absorption (Schultz et al., 2000; Jain et al.,
2006; Huang et al., 2007; Murphy et al., 2008).
Size also provides important control over many of the physical
and chemical properties, including luminescence, conductivity,
and catalytic activity. AuNPs’ absorption and scattering propor-
tions depend on the AuNPs size (Cao et al., 2002). AuNPs with
a diameter smaller than 20 nm essentially show absorption, but
when the size increase to 80 nm the ratio of scattering to absorp-
tion also increases. As the size of the AuNPs increases, light can
no longer polarize the nanoparticles homogeneously and higher
order modes at lower energy dominate. This causes a red-shift
and broadening of the surface plasmon band. Small AuNPs, like
those with 13 nm of diameter, absorb green light, which corre-
sponds to a strong absorption band at 520 nm in the visible light
spectrum. However, solutions of AuNPs appear red in color. For
smaller AuNPs (i.e., 5 nm diameter), surface electrons are oscil-
lated by the incoming light in a dipole mode, but the SPR is very
sensitive to the composition, size, shape, inter-particle distance
and environment (dielectric properties) of the AuNPs (Pellegrino
et al., 2005; Sperling et al., 2006).
In all synthesis methods reported so far, a reducing and a sta-
bilizing agent is added to prevent the particles from aggregating.
The type of stabilizer affects the selection of further biofunc-
tionalization strategies, as for certain strategies a good colloidal
stability at a broad range of pH and ionic strength is required.
Although a wide variety of nanoparticles can be stabilized by
a large range of stabilizers (ligands, surfactants, polymers, den-
drimers, biomolecules) (Sperling and Parak, 2010), the most
robust nanoparticles are covered by thiol molecules using the
strong gold–S bond between the soft acid Au and the soft thiolate
base (Giersig and Mulvaney, 1993). Thus, if a bifunctional thio-
lated stabilizer or even a mixture of them is used (e.g. thiolated-
PEGmolecules having carboxylic, amine, azide groups, etc.), then
it is possible to stabilize and introduce chemical functionalities in
a single step. This allows further attachment of biomolecules in a
controlled way by covalent immobilization strategies that we will
discuss in the following sections.
MAGNETIC NANOPARTICLES
Magnetic nanoparticles (MNPs) constitute an important class
of nanomaterials widely studied for their potential use in
biomedicine fields, such as imaging, cell labeling, hyperthermia
and drug and gene delivery (Pankhurst et al., 2003; Barakat, 2009;
Berry, 2009). MNPs can be classified as metal, alloys or oxides,
and are generally based on elements such as iron, cobalt, nickel,
or manganese among others (Pankhurst et al., 2009). From the
aforementioned, iron-based NPs are the most studied, since iron
is believed to be biocompatible (Hanini et al., 2011). Other ele-
ments, such as cobalt or nickel are reported to be more toxic
(Fang and Zhang, 2009). Iron oxide NPs (IONPs) are composed
of magnetite (Fe3O4) or maghemite (γ-Fe2O3), nanocrystallites.
Most of MNPs’ applications are a consequence of their mag-
netic properties, which greatly differ from those of the bulk
material. When small enough, MNPs present superparamagnetic
behavior at room temperature, meaning that they become mag-
netized upon exposure to an external magnetic field but lack
remnant magnetization once the external field is removed (Jun
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et al., 2008). Consequently, MNPs do not agglomerate in the
absence of the magnetic field, which is essential for in vivo
applications (Yoo et al., 2011). This characteristic is rather impor-
tant in applications, such as magnetic hyperthermia. The MNPs’
capacity of converting the energy of an alternate magnetic field
into heat (Rosensweig, 2002) and the extra sensitiveness of tumor
cells to an increase in temperature (van der Zee, 2002) are the
two pillars of magnetic hyperthermia in cancer. Since the late
50’s, when Gilchrist et al. (1957) first reported the use of MNPs
to heat tissue samples, to nowadays, magnetic hyperthermia has
evolved considerably and is a key area of interest in cancer therapy
with several studies showing the benefit of employing magnetic
materials in hyperthermia strategies (Jordan et al., 1993, 2001;
Johannsen et al., 2010; Laurent et al., 2011). Several groups
have reported noteworthy results in clinical trials where magnetic
hyperthermia shows effectiveness in tumor cell destruction with
impressive targeting, thus minimizing significantly side effects
(Johannsen et al., 2005; Liu et al., 2011; Zhao et al., 2012b).
There are a wide variety of methodologies used for MNP
synthesis, including physical or wet chemical approaches.
Concerning wet chemical approaches, there are somemethodolo-
gies, such as coprecipitation (Perez et al., 2002) or reverse micelles
precipitation (Liu et al., 2000) that provide directly water soluble
MNPs with an organic layer with chemical moieties for narrow
size distribution of MNP. However, common synthetic strategies
traditionally render MNPs soluble only in organic solvents. Their
use in bioapplications imply an additional step where adequate
chemical moieties are introduced by several strategies (e.g. use
of amphiphilic polymers, silanization, replacing and/or modify-
ing the surfactant layer) in order to allow silanization, their water
transference and further biofunctionalization.
QUANTUM DOTS
Quantum dots (QDs) are nanoparticles composed of semicon-
ductor materials from III-V or II-VI groups of the periodic table,
such as ZnS, ZnSe, CdS, CdSe, CdTe, InP, and others (Donega,
2011). Their reduced size induces a shift of the electronic excita-
tions to higher energy, concentrating the oscillator strength into
just a few transitions, conferring unique quantum-confined pho-
tonic and electronic properties (Alivisatos, 1996; Alivisatos et al.,
2005). Although physically larger than organic dyes and fluo-
rescent proteins, their cumulative optical properties offer great
biological utility. With tunable core sizes, it is possible to attain
a broad adsorption profile, narrow size, and symmetric photo-
luminescence spectra depending of the fundamental materials.
QDs also show strong resistance to photobleaching and chemical
degradation, as well as significant photostability and high quan-
tum yields (Ghanem et al., 2004; Xu et al., 2006; Algar et al., 2011).
Their potential as biological labels was first demonstrated
by Nie and Alivisatos groups in 1998, turning the focus into
bioapplications of QDs. The method relies on a ligand exchange
strategy is based on the replacement of the original hydropho-
bic ligands adsorbed onto the surface of QDs with biofunctional
molecules, such as protein transferrins. These QDs were suscepti-
ble to effective receptor-mediated endocytosis in cultured HeLa
cells. Since these first demonstrations of QDs potential, their
unique properties have been continuously optimized and applied
in a plethora of bioapplications, ranging from fluorescent probes,
biosensors to therapeutics and theranostic agents (Akerman et al.,
2002; Smith et al., 2006; Li et al., 2009; Liu et al., 2010; Ruan et al.,
2012; Singh et al., 2012).
Once QDs that show paramount optical properties are those
synthesized in organic media, numerous methods have been
developed for creating hydrophilic QDs (Medintz et al., 2008).
The first approach is commonly designated as “ligand exchange”
(Gill et al., 2008), where the hydrophobic layer of the organic
solvent may be replaced by biofunctional molecules containing a
soft acidic group (i.e., thiol, sodium thiolycolate) and hydrophilic
groups (i.e., carboxylic, aminic groups) (Wang et al., 2008). A sec-
ond approach usually consists in adding a particular shell to the
nanoparticles that can be further functionalized with additional
biomolecules or polymers (Koole et al., 2008; Zhang et al., 2008).
BIOFUNCTIONALIZATION OF INORGANIC NANOPARTICLES
Nanoparticles with unique and broad-based optical properties,
ease of synthesis and facile surface chemistry and functionaliza-
tion within appropriate size scale are generating much enthusi-
asm in biotechnology and biomedicine, with particular emphasis
in clinical diagnostics and therapy. However, for the biological
application of these NPs, it is necessary their functionalization
with one or several biomolecule (Figure 1), such as DNA/RNA,
oligonucleotides (i.e., ssDNA/RNA, dsDNA/RNA), peptides and
antibodies, fluorescent dyes, polymers (i.e., PEGs), drugs, tumor
FIGURE 1 | Schematic representation of a multifunctional nanocarrier.
These innovative NPs comprise nucleic acids such as RNA and DNA used
for gene silencing approaches and in colorimetric assays, respectively.
Aptamers and anticancer drug molecules are also used for delivery to the
target tissue. Carbohydrates may be useful as sensitive colorimetric
probes. PEG is used to improve solubility and decrease immunogenicity.
Responsive nanocarriers can also trigger reaction upon external stimuli
through the functionality of valuable tumor markers, peptides,
carbohydrates, polymers and antibodies that can be used to improve
nanocarrier circulation, effectiveness, and selectivity. Multifunctional
systems can also carry fluorescent dyes that are used as reporter
molecules tethered to the particle surface and employed as tracking and/or
contrast agents.
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markers, enzymes and other proteins that will introduce the
required bio-functionalities.
Ultimately, the conjugation strategy is directly dependent on a
numbers of factors such as size, surface chemistry and shape, as
well as the type of ligands and functional groups to exploit in the
functionalization. Also, the type of biological molecule and the
final application of the nanoparticle conjugate are crucial when
evaluating the conjugation strategy. Next, we summarize the most
frequently used biofunctional molecules used to introduce one or
several biological activities to the NP.
COMMON BIOFUNCTIONAL SPECIES
Polymer coatings—poly(ethylene glycol)
For their use as potential delivery devices in vivo, the aforemen-
tioned inorganic nanoparticles must have long plasma half-lives.
In this sense, poly(ethylene glycol) (PEG) is the most widely used
macromolecule to prolong nanocarriers half-life. In fact, PEGs
have a strong effect on nanoparticle structure, stabilization and
biodistribution both in vitro and in vivo (Akerman et al., 2002;
Daou et al., 2009; Boeneman et al., 2010; Maldiney et al., 2011).
These long-circulating nanoparticles have the ability to circulate
for a prolonged period of time and target a particular organ, as
carriers of DNA in gene therapy, or to deliver proteins, peptides
and drugs (Langer, 2000; Bhadra et al., 2002; Kommareddy et al.,
2005; Lee and Kim, 2005).
For systemic applications, the development of surface func-
tionalized and long-circulating NPs as cellular probes and delivery
agents is highly desired for passive targeting to tumors and
inflammatory sites. PEG-modification of NPs affords long cir-
culating property by evading macrophage-mediated uptake and
removal from the systemic circulation. Owing to its simple struc-
ture and chemical stability, it is a prototype of an inert and
biocompatible polymer (Sperling and Parak, 2010; Verma and
Stellacci, 2010). When bound to surfaces, PEG prevents other
molecules to bind by steric effects. In fact, the molecules are not
attracted by electrostatic forces and cannot penetrate the hydrated
PEG layer, producing an inert hydrophilic surface. Moreover, PEG
modified nanoparticles are more stable at high salt concentrations
and in biological environments, avoiding non-specific binding to
proteins and cells (Sperling and Parak, 2010). This is particularly
important for in vivo applications because once the NPs are in the
bloodstream, a portion of the plasma proteins that can adsorb
to the surface (opsonins), may promote NPs recognition by the
mononuclear phagocyte system (MPS), and consequently lead to
rapid removal of the NPs from circulation (Bertrand and Leroux,
2012). To date, there is a general consensus that to prolong NPs
half-life in the organism, PEGs’molecular weight, grafting density
and chain architecture must be optimized (Li and Huang, 2010;
Grazú et al., 2012). For instance, Xie and coworkers showed that
MNPs functionalized with PEG with molecular weights higher
than 3000Da were not taken up by macrophages in vitro, while
extensive uptake was observed for PEG 600-coated MNPs (Xie
et al., 2007).
Consequently, functionalization of NPs with a high density of
PEG of an adequate length not only increases the colloidal stabil-
ity of the modified NPs but also their plasma half-life. However,
to provide PEGylated NPs with targeting and therapeutic activity,
as well as with the ability of crossing different biological mem-
branes, they must be conjugated with a variety of biologically
relevant ligands, such as cell/tumor penetrating peptides, tumor
markers, and therapeutic agents (siRNAs, drugs). Concerning
gold NPs, one of the main strategies is to assemble PEG and
mixed biomolecule/PEG monolayers on the nanoparticles’ sur-
face. Liu et al. showed an escalation in the NPs’ stability with
increasing PEG length, decreasing nanoparticle diameter, increas-
ing PEG mole fraction and mixed monolayers prepared via the
sequential addition of PEG followed by a peptide. In this man-
ner, NPs were more stable than those prepared via simultaneous
co-adsorption. These modified NPs were able to target the cyto-
plasm of HeLa cells, being the cellular uptake quantified using
inductively coupled plasma optical emission spectrometry (Liu
et al., 2007). Sanz et al. also obtained polyvalent PEGylated AuNPs
with a similar strategy. The authors developed an approach to
attach specific biomolecules to the AuNPs’ surface and their
effect in the functionalization with other specific derivatives. The
effect of biofunctional spacers, such as thiolated PEG chains
and a positive peptide (TAT) in dsRNA loading on AuNPs was
reported. The authors hypothesized that the loading of oligonu-
cleotides onto the AuNP surface may be controlled by ionic and
weak interactions positioning the entry of the oligonucleotide
through the PEG layer, by a synergistic effect of the TAT pep-
tide and PEG chains with specific functional groups, enhancing
the dsRNA loading onto AuNPs (see Figure 2) (Sanz et al.,
2012).
Another approach to link biomolecules to PEGylated AuNPs is
making use of PEG as a spacer. This requires the use of bifunc-
tional PEG chains that contain thiol at one end and a suitable
functional moiety at the other (e.g. amino, carboxylate groups).
Recently, Oh et al. described a different approach, where in a
one-phase synthesis AuNPs were conjugated with PEG ligands
yielding a narrow size distribution of highly stable NPs in the
presence of high salt concentrations over a wide range of pHs
(Oh et al., 2010b). One way or another, functional moieties of
PEG ligands allow for further coupling of target biomolecules.
Consequently, surface modification of gold clusters through PEG
spacers (Kanaras et al., 2002; Simpson et al., 2011) would allow
the modified nanoparticles to remain in the systemic circulation
for prolonged periods and provide flexibility for efficient inter-
action with a target. Besides, using a combination of different
bifunctional PEG spacers, gold nano-platforms can be multifunc-
tionalized with a variety of biologically-relevant ligands such as
cell penetrating peptides, fluorescent dyes, tumor markers and
siRNA (Conde et al., 2012a).
PEGylated QDs have also been successfully produced for effec-
tive in vitro and in vivo circulation (Skaff and Emrick, 2003; Hu
et al., 2010; Prow et al., 2012; Yang et al., 2012b). Recently, Poulose
et al. developed highly biocompatible PEG functionalized in cad-
mium chalcogenide luminescent QDs (CdS, CdSe, and CdTe) as
an imaging tool for early diagnosis of cancer by targeting a cancer
cell line (Poulose et al., 2012).
Although PEG is really useful to prolong NPs’ blood half-life,
it is known that in some cases PEG can hamper cargo release
or hide other functional domains once the NP accumulates at
the desired target area (Sawant and Torchilin, 2012). Inclusion of
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FIGURE 2 | Polyvalent PEGylated gold nanoparticles. (A) Bioconjugation
of the surface-modified gold nanoparticles with different thiol-PEG layer
composition (SH-EG(7)-CH2-COOH and SH-(CH2)3-CONH-EG(6)-CH2-N3),
TAT peptide and thiol-dsRNA oligonucleotide. (B) Mechanism for the
enhancement of the dsRNA loading on AuNPs functionalized with PEG
chains and TAT peptide. The azide group has a resonant structure with
a positively polarized behavior that can attach the negatively charged
thiolated oligonucleotide to the gold surface. The azide-containing chain
also encloses an amide group near the gold surface that could play a
role in approaching the thiol group of the oligonucleotide to the gold
surface. This amide group could form a hydrogen bond with one of the
hydroxyl groups of the ribose group near the thiol group on the
oligonucleotide. (C) Determination of the number of TAT chains bound
to AuNPs by the EDC reaction as a function of the initial peptide
concentration in the reaction mixture. Blue bars AuNP@COOH/N3 and
red bars AuNP@COOH. (D) Loading of thiolated oligonucleotide
(HS-dsRNA) on AuNPs functionalized with TAT peptide and with both
PEG-azide and PEG-COOH and only with PEG-COOH. Blue bars
AuNP@COOH/N3 and red bars AuNP@COOH (Sanz et al., 2012).
Reproduced with permission from Sanz et al. (2012), Copyright 2013.
stimulus-sensitive detachable PEG is a possible solution to over-
come these drawbacks, so that cargoes can be released or other
ligands unveiled in response to microenvironmental conditions.
For instance, Harris et al. functionalized MNPs with a PEG teth-
ered by an MMP-2 cleavable substrate (Harris et al., 2008), being
MMP-2 a protease upregulated in angiogenesis and metastasis.
Once NPs reached the tumor, the polymer was cleaved, unveil-
ing the cell penetrating peptide, resulting in increased uptake by
cells when compared to non-cleavable PEG.
Fluorescent dyes
Several studies report on the modulation of fluorophores at the
vicinity of nanoparticles (Kang et al., 2011; Rosa et al., 2011),
which has found application in a variety of systems to detect
biologically relevant targets.
Several methods based on the quenching of fluorescence have
been proposed for DNA detection consisting of fluorophore-
labeled ssDNA electrostatically adsorbed onto AuNPs (Ray et al.,
2006), where the presence of a complementary target triggers
desorption of the newly formed dsDNA from the nanostruc-
tures due to the electrostatic variation between ssDNA and
dsDNA, and fluorescence emission is restored. Also, fluorescence
quenching of fluorophores close to gold nanocarriers function-
alized with thiol-modified oligonucleotides has been explored
in different conformations (Wu et al., 2006; Tang et al., 2008).
Tang et al. proposed a method to probe hydroxyl radicals using
an AuNP-oligonucleotide-FAM system where the hydroxyl rad-
ical promotes strand breakage and consequent release of FAM,
restoring the previously quenched fluorescence (see Figure 3)
(Tang et al., 2008). The same quenching mechanism was used
to detect specific DNA strands using two probes (one with an
AuNP label and another labeled with TAMRA) that hybridize to
two DNA sequences near each other (Wu et al., 2006), bringing
the fluorophore and AuNP close enough to quench fluorescence
emission.
Proteins have also been probed through nanoparticle
fluorescence-mediated systems, especially for protein detection
via quenching, through the interaction with fluorescent AuNPs
(Mayilo et al., 2009; He et al., 2010; Lacerda et al., 2010). Due
to their efficient proximity-dependent fluorescence quenching
they can be used per se or as part of more elaborate conjugates
(i.e., with QDs) (Pons et al., 2007). One example is the work of
De et al. where the interaction between AuNPs and the green
fluorescent protein (GFP) was employed to detect proteins in
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FIGURE 3 | Fluorescent-AuNPs. (A) Chemical structure of a
FAM–DNA–AuNP and schematic illustration of its FRET-based operating
principles. (B–E) Confocal fluorescence and phase-contrast images of
living cells. (B) Fluorescence image of macrophages incubated with the
probe for 30min at 37◦C. (C) Fluorescence image of probe-stained
macrophages stimulated with PMA for 1 h at 37◦C. (D) Bright field image
of live macrophages shown in (C), confirming their viability. (E) AO
staining of probe-loaded macrophages, confirming their viability (Tang
et al., 2008). Reproduced with permission from Tang et al. (2008),
Copyright 2013.
biological matrices, such as serum (De et al., 2009). By correlating
the variation in fluorescence intensity with specific proteins of
interest, they were able to identify proteins such as fibrinogen,
human serum albumin and immunoglobin G, among others
with over 97% accuracy.
In essence, fluorescent-nanoparticle systems can be used for
sensing by exploring a typical FRET in order to provide effi-
cient in vivo detection and tumor targeting. These nanocarriers
symbolize an important class of materials with unique features
suitable for biomedical imaging applications such as increased
sensitivity in detection, high quantum yields for fluorescence and
a bounty of novel applications in optics and nanophotonics for
molecular diagnostics (Conde et al., 2012d).
QDs are often used as fluorescent molecules per se, since they
are semiconductor nanoparticles with narrow, tunable, symmet-
rical emission spectra and high quantum yields (Weller, 1993;
Bruchez et al., 1998). These characteristics were evidenced by Wu
et al. using QDsmodified with different cellular antigens enabling
the simultaneous detection of two different targets in the same
cell (Wu et al., 2003). It was also shown their higher brightness
and photobleaching resistance when compared to organic dyes.
These properties make QDs exceptional substitutes as fluores-
cence labels (Xing et al., 2006; Smith et al., 2010; Smith and Nie,
2012).
The inclusion of dyes onto MNPs allows the creation of
multifunctional NPs, which might be used for MRI and opti-
cal imaging. These dual MNPs allow for multimodal imaging,
which implies that the limitations of one imaging modality could
be compensated by the other, creating a complementary effect
(Louie, 2010). For instance, Medarova and co-workers reported
the synthesis of a multifunctional MNP that included near-
infrared optical imaging dye, peptides for membrane transloca-
tion and synthetic siRNA targeting a specific gene (Medarova
et al., 2007). In vivo accumulation of the MNPs was assessed by
MRI and optical imaging and the silencing efficiency was also
probed by in vivo optical imaging.
Nucleic acids
Watson and Crick first described DNA as two helical chains each
coiled around the same axis, consisting of simple and repeating
units called nucleotides with backbones made of sugars and phos-
phate groups joined by ester bonds that run in opposite directions
to each other. The importance of this molecule within living cells
is undisputable (Watson and Crick, 1953). Besides their biological
function, nucleic acids can be employed as polymeric molecules
which will bind specifically to targets thanks to Watson–Crick
base pairing (Fichou and Ferec, 2006).
Mirkin et al. (1996) described the use of a cross-linking
method that relies on the detection of single-stranded oligonu-
cleotide targets using two different gold nanoprobes, each of them
functionalized with a DNA-oligonucleotide complementary to
one half of the given target. This functionalization was achieved
using the strong affinity of thiol or disulfide groups to the gold
surface of the NPs, forming quasi-covalent bonds. By modify-
ing a nucleic acid molecule with a thiol group in either the 5′
or the 3′ end it is possible to fine-tune the DNA assembly into
the gold surface (Hurst et al., 2006), controlling variables such
as salt concentration, oligo/NP ratio or nanoparticle size. This
phenomenon indicates the potential of AuNPs modified with
DNAs to be applied in biosensing or as DNA probes for diagno-
sis (Cao et al., 2005). These assays became an important mark
in detection once they have PCR-like sensitivity, selectivity for
target sequences, capacity for massive multiplexing, and most
importantly, have the ability to be performed at the point of care.
Using a fluorescence-based method, Demers et al., have deter-
mined the number of thiol-derivatized single-stranded oligonu-
cleotides bound to AuNPs and their extent of hybridization
with complementary oligonucleotides in solution (Demers et al.,
2000). Also, using a fluorescence method, Conde et al. reported
the potential of a single molecular nanoconjugate to intersect all
RNA pathways: from gene specific downregulation to silencing
the silencers, i.e., siRNA and miRNA pathways, by using gold
nanobeacons (Figure 4). These nanoconjugates functionalized
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FIGURE 4 | Silencing the Silencers with hairpin-DNA-AuNPs—Gold
nanobeacons. (A)SpecificAu-nanobeacons are capable of intersectingmiRNA
pathway, leading to recovery of previously downregulated gene expression
while simultaneously discriminating cells where silencing is occurring. The
fluorescence signal may allow for tracking cell internalization and sub-cellular
localization. The Au-nanobeacons’ potential for anti-cancer therapeutics via the
silencing of the silencers is demonstrated by blocking the endogenous
microRNA pathway via an Anti-miR Au-nanobeacon complementary to the
mature microRNA-21 (miR-21), commonly upregulated in cancer phenotypes.
(B,C) Au-nanobeacons silencing of endogenous silencers—silencing of
miR-21. Confocal imaging (scale bar, 10μm) shows internalization of 50 nM
(B) Anti-miR Au-nanobeacon 50 nM and (C) Nonsense Au-nanobeacon. Target
(mature miR-21) recognition leads to change of Anti-miR Au-nanobeacon
conformation in the cytoplasm with concomitant fluorescence signal (red,
Cy3) encircling the cell nuclei (blue, DAPI) (Conde et al., 2013b). Reproduced
with permission from Conde et al. (2013b), Copyright 2013.
with a fluorophore labeled hairpin-DNA are capable of effi-
ciently silencing single gene expression, exogenous siRNA and
an endogenous miRNA while yielding a quantifiable fluorescence
signal directly proportional to the level of silencing. Inhibition of
gene expression was achieved with concomitant increase of the
gold nanobeacons’ fluorescence that can be used to assess the
silencing effect (Rosa et al., 2012; Conde et al., 2013a,b, 2014b).
Moreover, AuNPs functionalized with ssDNA are also capa-
ble of specifically hybridizing to a complementary target for
the detection of a particular nucleic acid sequence in biological
samples (Sato et al., 2003; Storhoff et al., 2004; Baptista et al.,
2005; Thaxton et al., 2006). The impact of advances in these
nanoparticle-based assays for specific detection of bioanalytes of
clinical interest is particularly relevant in biodiagnostics, making
them ideal candidates for developing biomarker platforms.
However, nucleic acid molecules are also capable of establish-
ing ionic interaction in gold surface. It has been shown that both
thiol-ssDNA and dsDNA stabilize gold nanoparticle dispersions,
but possible non-specific interactions between the hydrophobic
DNA bases and the gold surface promote interparticle inter-
actions and cause aggregation within a short period of time
(Cardenas et al., 2006). The charge repulsion among DNA strands
and between DNA and AuNPs can be reduced by adding salt,
reducing pH or by using non-charged peptide nucleic acid (PNA)
(Zhang et al., 2012b).
Moreover, Conde et al. reported the design of two approaches
(see Figure 5) for the binding of siRNA molecules to multifunc-
tional AuNPs: (Figure 5A) the binding of the negatively charged
siRNA through ionic interactions to the modified gold surface
(ionic approach) and (Figure 5B) the use of thiolated siRNA
for the binding to the nanoparticle through the strong interac-
tion gold-thiol (covalent approach) (Conde et al., 2012a). The
covalent approach was evaluated in a lung cancer mouse model
to evaluate the inflammatory response and therapeutic siRNA
silencing via RGD-nanoparticles. This study reported the use of
siRNA/RGD gold nanoparticles capable of targeting tumor cells
in two lung cancer xenograft mouse models, resulting in success-
ful and significant c-Myc oncogene downregulation followed by
tumor growth inhibition and prolonged survival of the animals
(Conde et al., 2013c).
Modulation of the physicochemical properties of the gold
nanocarriers can be easily achieved by adequate synthetic strate-
gies and give AuNPs advantages over conventional detection
methods currently used in clinical diagnostics and therapy.
Simple and inexpensive methods based on these bio-nanoprobes
were initially applied for detection of specific DNA sequences and
are currently being expanded to clinical diagnosis (Baptista et al.,
2008).
QDs have also been functionalized with nucleic acids and
extensively used as DNA sensors (Crut et al., 2005; Dubertret,
2005; Zhang et al., 2005a; Choi et al., 2009; Ye et al., 2009; Zhang
and Hu, 2010). For in vitro test of target DNA, QDs based FRET
pairs turned out to be of great use. The method developed by
Zhang et al. using QDs-Cy5-labeled reporter oligonucleotide con-
jugates, capable of detecting low concentrations of DNA in a
separation-free format. This system uses QDs linked to DNA
probes to capture DNA targets and successfully detect a point
mutation (Zhang et al., 2005a).
Owing to their unique optical properties, QDs have also
been applied for multiplex detection of analytes with single-
molecule detection. Zhang et al. reported the use of a single
QD-based nanosensor for multiplex detection of HIV-1 and HIV-
2 at single-molecule level in a homogeneous format (Zhang and
Hu, 2010). These QD-based nanosensors have several advan-
tages such as extremely low sample consumption, high sensitivity,
short analysis time and have the potential to be applied for rapid
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FIGURE 5 | Gold nanoparticles functionalized with multiple
biomolecules: PEG, cell penetration peptide (TAT), ammonium
quaternary groups, and siRNA. Two different approaches were employed
to conjugate the siRNA to the AuNPs: (A) ionic approach, interaction of the
negatively charged siRNA to the modified surface of the AuNPs through
ionic interactions; (B) covalent approach, use of thiolated siRNA for gold
thiol binding to the NPs.
point-of-care testing, gene expression studies, high-throughput
screening, and clinical diagnostics.
When modified with DNA, QDs were successfully employed
in the detection of respective complementary DNA strands via
FRET. Sub-nanomolar detection limits have been reported (Zhou
et al., 2008a; Singh and Strouse, 2010). The strategy success
is directly related to the covalent coupling of the nucleic acid
molecule to the QD, controlling the donor-acceptor distance,
fundamental in FRET-based biosensors.
QDs can also be used in gene delivery. Jin-Ming Li et al. devel-
oped a series of QDs functionalized with β-cyclodextrin coupled
to amino acids. Using the β-cyclodextrin as a vector for delivering
doxorubicin (DOX) and electrostatically binding MDR1 siRNA,
this strategy allowed for simultaneous chemotherapy and gene
silencing. The authors observed that in HeLa cells it was pos-
sible to induce apoptosis due to the intracellular accumulation
of Dox and also reduced levels of MDR1 gene expression. These
multifunctional QDs are promising vehicles for the co-delivery
of nucleic acids and chemotherapeutics, as well as for real-time
tracking of treatment (Li et al., 2012).
QDs-siRNA conjugates have also been used for imaging
and gene silencing approaches (Derfus et al., 2007; Tan et al.,
2007; Yezhelyev et al., 2008; Zhao et al., 2010; Li et al., 2011,
2012). For example, Yezhelyev et al. developed multifunctional
nanoparticles for siRNA delivery and imaging based on the
use of QDs and proton-absorbing polymeric coatings (proton
sponges). The authors demonstrated a dramatic improvement
in gene silencing efficiency and simultaneous reduction in cel-
lular toxicity, when compared with existing transfection agents.
Additionally, QD-siRNA nanoparticles are also dual-modality
optical and electron-microscopy probes, allowing real-time track-
ing and ultrastructural localization of QDs during delivery and
transfection (Yezhelyev et al., 2008).
MNPs have also been frequently used as platforms for the
delivery of DNA or siRNA, as they can be used to track their
biodistribution by MRI. For instance, Kumar et al. synthesized
multifunctional MNPs by attaching a near-infrared optical dye
Cy5.5 and a peptide that targets the tumor specific antigenmucin-
1 to cross-linked dextran coated SPIONs (Kumar et al., 2010). The
delivery of the nanosystem to tumors in mice was imaged either
in vivo or ex vivo by MRI and optical imaging.
On the other hand, the functionalization of plasmid DNA and
siRNA to MNPs has been widely reported, as MNPs are used
as tools for magnetofection, that is to say, the enhanced deliv-
ery of nucleic acids associated to MNPs using external magnetic
fields (Scherer et al., 2002; Dobson, 2006; Plank et al., 2011).
Using magnetofection the transfection efficiency can be highly
improved when compared with transfections carried out with
non-magnetic gene delivery systems in a variety of primary cells
and cell lines (Mykhaylyk et al., 2007; Prijic and Sersa, 2011).
Although magnetofection results are promising in vitro, and sev-
eral studies have reported the systemic delivery of nucleic acids
using MNPs in vivo, not many of them use an external magnetic
field to enhance the accumulation of the MNPs in the targeted
area (Plank et al., 2011). Thus far, the most promising appli-
cation of magnetofection as an in vivo cancer therapy has been
reported by Namiki et al. (2009). The authors formulated oleic
acid-coated MNPs assembled with cationic lipid shells, and func-
tionalized them with an appropriate siRNA sequence to knock
down the epidermal growth factor receptor (EGFR) mRNA, as
it is overexpressed in tumor blood vessel endothelium. After sys-
temically injecting the complex tomice tumors, the authors found
a 50% reduction in tumormass when amagnetic field was applied
compared to the control group without magnetic field.
Peptides
Peptides are short chains of amino acid monomers linked by
amide bonds and are distinguished from proteins on the basis
of size, once they only contain ∼50 amino acids or less. Peptides
can be found naturally or synthetically and have the potential for
the stabilization and biofunctionalization of NPs. For instance
Wang et al. demonstrate that multiple functional peptide stabi-
lized AuNPs are readily obtained in a one-step surface coating
procedure and that the surface functionalities can be selectively
addressed on a microarray. The authors developed a straightfor-
ward route to stable AuNPs, both with single and with dual bio-
logical functionality. The particles exhibit the specific recognition
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properties of the biological cargo without any indication of non-
specific binding or particle aggregation (Wang et al., 2005).
The stability conferred by peptide ligands usually depends
on their length, hydrophobicity, and charge and in some cases
resulted in further improved stability. Actually, Levy et al.
designed a pentapeptide ligand, CALNN, which converts citrate
stabilized AuNPs into extremely stable, water-soluble AuNPs with
some chemical properties analogous to those of proteins. These
peptide-capped AuNPs can be freeze-dried and stored as pow-
ders that can be subsequently redissolved to yield stable aqueous
dispersions (Levy et al., 2004).
Biofunctional peptide sequences include “membrane translo-
cation signals” like the HIV-TAT peptide sequence (de la Fuente
and Berry, 2005; Berry et al., 2007; Conde et al., 2012a), which
is capable of transporting nanoscale materials across cellular
membranes and “nuclear locating signals” that could be used
for further intracellular targeting (Nativo et al., 2008; Chithrani,
2010). In fact, de la Fuente et al. developed AuNPs functional-
ized with HIV-Tat peptide used to achieve cytoplasm and the cell
nucleus. One of the major drawbacks of these cell penetrating
peptides is that they are not cell specific and that they can remain
entrapped in endosomes (Gump and Dowdy, 2007). To overcome
these limitations, fusogenic peptides that are able to escape from
endosomes or homing peptides capable of reaching specific tis-
sues or cells have been developed (Li et al., 2004; Ruoslahti et al.,
2010).
QDs labeled with these types of peptides have been extensively
prepared using various strategies (Chen and Gerion, 2004; Cai
and Chen, 2008; Curnis et al., 2008). For example, Akerman et al.
show that ZnS-capped CdSe QDs coated with a lung-targeting
peptide accumulate in the lungs of mice after intravenous injec-
tion, whereas two other peptides specifically direct QDs to blood
or lymphatic vessels in tumors (Akerman et al., 2002). Curnis
et al. also found that a cyclic Ciso DGRC peptide coupled to QDs
could bind alphavbeta 3 integrin and co-localize with several anti-
bodies in human renal cell carcinoma tissue sections, indicating
that this peptide could efficiently recognize endothelial cells of
angiogenic vessels (Curnis et al., 2008). Cai et al. also used a thi-
olated arginine-glycine-aspartic acid (RGD) peptide to conjugate
to the QDs and applied the QDs peptide bioconjugates for tumor
vasculature targeted imaging (Cai and Chen, 2008). However, if
crossing the vascular wall is needed, these RGD peptides need to
be improved. The Ruoshlati group reported a cyclic peptide iRGD
that can combine the tumor-homing RGD sequence with a tissue
penetration motif (Sugahara et al., 2009). Therefore, the homing
sequence directs the peptide to the tumor vascular endothelium,
while the tissue penetration motif, once activated by a pro-
tease, binds to a different receptor (neuropilin-1), which mediates
extravasation and tissue penetration. As a proof of concept, iRGD
peptide-linked iron oxide nanoworms could be detected by MRI
throughout a tumor once injected in vivo to mice. Recently, the
same group combined two different peptides with the magnetic
nanoworms to image and treat mice with glioblastoma, one of
the most difficult tumors to treat (Agemy et al., 2011). While
the CGKRG peptide targets the NPs to tumor vascular cells and
into their mitochondria, the other peptide acts as a pro-apoptotic
drug. By co-injecting these NPs with iRGD, most of the tumors
were eradicated or their development delayed in two glioblastoma
mouse models.
Despite the extraordinary rapid development in strategies for
nanoparticle conjugation with peptides, relatively little is known
about NP behavior in the immune system, which is responsible
for maintaining body integrity and preventing external inva-
sion. Bastus et al. described the interaction between murine
bone marrow macrophages and gold nanoparticle peptide con-
jugates. In the presence of conjugates, macrophage prolifera-
tion was stopped and pro-inflammatory cytokines were induced.
Furthermore, macrophage activation by AuNPs conjugated to dif-
ferent peptides appeared to be rather independent of peptide
length and polarity, but dependent on peptide pattern at the
nanoparticle surface (Bastus et al., 2009).
Proteins/antibodies
In Bionanotechnology, specific functions of proteins such as
antibody–antigen detection may also be very useful. Antibodies
(Abs) or immunoglobulins are a group of proteins that have a very
similar structure with four chains assembled in a Y shaped form,
containing two identical domains for antigen recognition (Fab
fragment), and two identical domains with effector functions (Fc
fragment). The main advantage of Abs or their fragments is that
the antigen-binding region is highly specific and different among
Abs (Arruebo et al., 2009). Therefore, different specificity can be
obtained using distinct Abs. However, attachment of Abs to the
surface of NPs can impair this function if the antigen binding
sites are sterically blocked upon conjugation. For this reason, the
Abs orientation is extremely important to produce effective and
bioactive antibody-nanoparticles.
In fact, de la Fuente et al. recently demonstrated that the com-
bination of a good Ab orientation along with the property of a
gold nanoprism to generate heat when illuminated with the cor-
rect wavelength enable visual detection of carcinoembryonic anti-
gen (CEA) by plasmonic-driven thermal sensing with sensitivities
up to the attomolar range in serum samples (Polo et al., 2013).
Immunoassays use the specificity and sensitivity of the
antibody-antigen interaction in order to detect and quantify the
amount of a specific analyte present in a sample. Effective conju-
gated antibodies can be used to constitute the desired functional-
ity of the nanocarrier itself for immunoassays (Han et al., 2003).
Actually, Putman et al. described the use of immunogold labels
as cell-surface markers of human lymphocytes in atomic force
microscopy. The AFM images reveal the colloidal gold particles on
the cell surface, with and without silver enhancement. Individual
immunogold particles are clearly resolved from the cell surface
thus determining the location of antigens (Putman et al., 1993).
Ni et al. described an immunoassay readout method based
on surface enhanced Raman scattering (SERS). The method
exploits the SERS-derived signal from reporter molecules that
are co-immobilized with biospecific species on gold colloids.
This concept is demonstrated in a dual analyte sandwich assay,
in which two different antibodies covalently bound to a solid
substrate specifically capture two different antigens from an aque-
ous sample. The captured antigens in turn bind selectively to
their corresponding detection antibodies. The detection antibod-
ies are conjugated with gold colloids that are labeled with different
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Raman reporter molecules, which serve as extrinsic labels for each
type of antibody (Ni et al., 1999).
More recently, Conde et al. developed a highly sensitive probe
for in vivo tumor recognition with the capacity to target spe-
cific cancer biomarkers such as EGFR on human cancer cells
and xenograft tumor models. The authors used ∼90 nm AuNPs
capped by a Raman reporter, encapsulated and entrapped by
larger polymers and a Food and drug Administration (FDA)
antibody–drug conjugate—Cetuximab (Erbitux®). These smart
SERS gold nanoantennas present a high Raman signal both
in cancer cells and in mice bearing xenograft tumors and the
Raman detection signal is accomplished simultaneously by exten-
sive tumor growth inhibition in mice. This approach seems to be
an innovative and efficient theranostics system for both tumor
detection and tumor cell inhibition at the same time (Conde et al.,
2014a).
QD-Antibody conjugates have also been widely used for
preparing bioconjugated QDs for in vitro bioassay applications
(Goldman et al., 2002; Hua et al., 2006; Tan et al., 2007; East
et al., 2011). In fact, Goldman et al. described the preparation
and characterization of bioinorganic conjugates made with highly
luminescent semiconductor CdSe-ZnS core-shell QDs and anti-
bodies for use in fluoroimmunoassays. QD-antibody conjugates
were successfully used in fluoroimmunoassays for detection of a
protein toxin (staphylococcal enterotoxin B) and a small molecule
(2,4,6-trinitrotoluene) (Goldman et al., 2002).
Concerning magnetic NPs, bioseparation is one of the main
applications of MNP-Ab conjugates. In fact, magnetic separation
of red blood cells using magnetic microspheres was reported as
early as 1977 (Molday et al., 1977). MNPs are used to purify and
concentrate different types of analytes in complex samples, such
as hormones in biological samples, antibiotics or bacteria in food
(Kuo et al., 2012; Svobodova et al., 2012; Xu et al., 2012). One
of the best known systems that employ MNPs for separation and
concentration is the bio-bar code technology originally described
by Nam et al. (2003). In this case, Abs specific for a target protein
are functionalized on the surface of MNPs, by sandwiching the
target between these MNPs and an amplifier AuNPs that is loaded
with a secondary Ab and oligonucleotides. When the specific tar-
get is sandwiched between the MNP and the AuNP, magnetic
separation of the complexed probes allows for the concentration
of the target within the sample. Afterwards, the oligonucleotides
are released and detected, giving rise to a substantial amplifica-
tion of the signal, and therefore lowering the detection limit to
attomolar concentrations (Goluch et al., 2006). In fact, the first
point-of-care nano-enabled medical diagnostic tool approved by
the FDA, known as Verigene System and commercialized by
Nanosphere Inc., is based on this biosensing strategy.
MNPs conjugated with Abs are also useful for the development
of a new class of diagnostics nanosensors, called magnetic relax-
ation switches (MRS).MRS have the potential to provide sensitive
and selective detection of a variety of molecular interactions with
minimal or no sample preparation (Perez et al., 2002). These
assays exploit the fact that whenMNPs recognize and bind biolog-
ical targets, they cluster, changing the spin-spin relaxation times
of water protons (T2). These changes in T2 between dispersed
and aggregated states of the MNPs can be monitored by nuclear
magnetic resonance (NMR) (Min et al., 2012). One of the greatest
advantages of these biosensors is that they employ radiofrequency
radiation which penetrates biological samples regardless of their
optical properties, and therefore can be used in complex samples
such as blood. Using this technology, Lee et al. reported the
first micro NMR biosensor, where tumor cells could be detected
employing MNPs functionalized with Abs on microliter sample
volumes and in multiplexed format (Lee et al., 2008). Since then,
the sensitivity of these biosensors has been greatly improved using
other highly magnetic MNPs (Lee et al., 2009), so that molecular
profiling of cancer cells obtained by fine-needle aspirates biopsies
within 60min is possible nowadays. Using different markers, the
authors reported 96% accuracy for establishing a cancer diagnosis
(Haun et al., 2011).
Other proteins have also been successfully conjugated with
NPs (Mattoussi et al., 2000; So et al., 2006a,b; Xia et al., 2008;
Roullier et al., 2009). Mattoussi et al. first described the electro-
static interactions between negatively charged lipoic acid capped
QDs and a positively charged recombinant protein (Mattoussi
et al., 2000). Prasuhn et al. also developed a QD protein FRET-
based biosensors used as caspase 3 proteolytic and Ca2+ sensors
(see Figure 6) (Prasuhn et al., 2010).
Similar to nucleic acids, proteins are known for their spe-
cific binding interactions and can act together with a wide range
of substrates and synthetic analogs. Consequently, high molec-
ular weight peptide ligands show potential for wide biological
applications and for stabilization and biofunctionalization of
nanocarriers.
Enzymes
Enzymes, as highly specialized protein catalysts, are commonly
used in biofunctionalization due to their potential in biotechnol-
ogy and biomedicine, because of the convenience in handling,
ease of separation from the reaction mixture and reuse, as well
as low product cost. The immobilization in NPs often reduces
diffusion limitations and/or enhances the catalytic activity of the
enzymes.
An important focus of the research on AuNPs based biosen-
sors is in enzyme electrodes. One recurrent example is glucose
biosensors. Zhang et al. (2005b) described the assembly of a
gold electrode modified via Au-S bond with AuNPs, where a
cystamine monolayer is chemisorbed, thus exposing an array of
amino groups. These are further reacted with aldehyde groups of
periodate oxidized glucose oxidase via Scchiff base reaction. In
this study, the NPs showed to act as conduction intermediates
facilitating electron transfer, with little effect on enzyme activity.
It was also shown that the sensitivity was improved as well as the
affinity for glucose, hence lowering the detection limits.
In another study, MNPs were modified with N-
phosphonomethyl iminodiacetic acid for immobilization of
urease. Thus, the surface coating was conferred with carboxyl
groups to which urease had been immobilized through carbodi-
imide reaction (Sahoo et al., 2011). The advantage of using MNPs
is the possibility of product isolation by a permanent magnet,
thus reducing costs. The authors also reported that the thermal
stability of the urease was increased, showing that MNPs may be
a promising material for storage and enzyme immobilization.
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FIGURE 6 | Quantum dot protein biosensors. (A) Schematic showing the
common design, chemical and sensing elements, including FRET-based
biosensors: (1) peptide modularity, (2) peptide labeling, (3) attachment to QDs,
and (4) FRET-based sensing for both the caspase 3 proteolytic sensor (left) and
Ca2+ sensor (right). The 4-pendant carboxyl groups that interact with Ca2+
ions are shown in red on the CaRbCl structure. Within the Ca2+ sensor
peptide sequence, Aib is the synthetic amino acid α-aminoisobutyric acid.
Reactive dye structures are shown where appropriate along with the chemical
linkages attaching them to the peptides. (B) Representative, superimposed
spectra collected from 550nm emitting QD donors surface functionalized with
85:15 DHLAPEG600-COOH/DHLA-PEG750-OMe ligands and covalently
conjugated to increasing molar ratios of Texas Red-labeled substrate peptide.
Samples excited at 350 nm. (C) Proteolytic assay data from exposing a
constant concentration of 550 nm emitting QDs conjugated to 4 Texas Red
substrate peptides to a constant concentration of caspase 3 enzyme. Derived
Km and Vmax values are given. An R2 = 0.98 was obtained for the fitting of
the curve. (D) Representative, superimposed, and deconvoluted spectra
collected from 580nm emitting QD donors self-assembled with increasing
CaRbCl-acceptor labeled peptides. Samples were excited at 350 nm.
(E) Normalized acceptor/donor PL area ratios for 580 nm QDs self-assembled
with ∼2 CaRbCl-acceptor labeled peptides exposed to selected ionic
materials. The ratio from the native unexposed sensor was set to an initial
value of 1 for comparison purposes (Prasuhn et al., 2010). Reproduced with
permission from Prasuhn et al. (2010), Copyright 2013.
When using enzyme-based biosensors the main concern is
reusability of the enzyme. Khoshnevisan et al. reported the use
of MNPs to circumvent this dilemma when using cellulase. The
enzyme was incubated with the MNPs and binding confirmed by
FT-IR. The authors show that immobilization grants higher sta-
bility to the enzyme, thus confirming that the use of MNPs in this
type of biosensors can be of great benefit (Khoshnevisan et al.,
2011).
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Imaging QDs in vivo is arduous due to the need of an external
source of light, which produces strong background autofluo-
rescence from ubiquitous endogenous chromophores. So et al.
proposed the ideal QD, where it would emit light with no
requirement for external excitation (So et al., 2006b). By modi-
fying QDs with Renilla reniformis luciferase the authors discard
the need of external excitation due to the phenomenon of bio-
luminescence resonance energy transfer (BRET). BRET occurs
naturally and it is analogous to FRET, but the donor energy comes
from a chemical reaction catalyzed by the donor enzyme. The
polymer coated CdSe/ZnS core-shell QDs dotted with carboxy-
late groups were incubated with R. reniformis luciferase, where
through carbodiimide reaction the amino groups of the enzyme
were coupled to the carboxylates. Thus, with a simple modifica-
tion the authors were able to mimic the natural BRET systemwith
self-illuminating QDs (So et al., 2006b).
Carbohydrates
Carbohydrates are, together with nucleic acids and proteins,
important molecules for life. Much is already known about the
structure, interactions and function of nucleic acids and proteins,
however, the role of carbohydrates in the cell is less clear (de la
Fuente and Penades, 2006). A characteristic feature of the biologi-
cal interactions where carbohydrates are involved is their extreme
low affinity that has to be compensated by multivalent presen-
tation of the ligands. Although individual carbohydrate interac-
tions are relatively weak, nature utilized multivalent interactions
between the cell surface ligands and their biological receptors to
modulate biological events such as the ones related to cell adhe-
sion, normal tissue growth and repair, viral/bacterial infection,
signaling transduction, trapping of leucocytes, and cancer trans-
fer. So the decoding of carbohydrate interactions opens up the
possibility to employ nanoparticles in diagnostics and/or ther-
apy (Dong, 2011). In fact, the unique physical, chemical and
optical properties of the nanocarriers with carbohydrate coating
comprise a series of advantages that range from ensuring water
solubility, biocompatibility and stability to targeting properties
(Garcia et al., 2010).
Among them, gold glyconanoparticles (glycoNPs) have drawn
attention owing to their well-defined features, such as water-
soluble carbohydrate-functionalized nanoclusters with a promis-
ing potential for chemical glycobiology, biomedicine, diagnostics
and clinical applications. In the last 10 years, Penades and co-
workers have extensively reported a pioneer integration of a
glyconanotechnology strategy based on the use of nanoparticles
to study and evaluate carbohydrate–carbohydrate, carbohydrate–
protein interactions (Figure 7) (de la Fuente et al., 2001, 2006;
Barrientos et al., 2003; de la Fuente and Penades, 2004, 2006),
which could be used as potential tools in anti-adhesive therapy
(Rojo et al., 2004), for cell–cell adhesion studies (de la Fuente
et al., 2005), prevention of pathogen invasion (Reynolds et al.,
2012) and for exploring blood–brain barrier permeability via
neuropeptide conjugation (Frigell et al., 2014).
Smaller carbohydrates, such as lactose, glucose and mannose
(Otsuka et al., 2001; Reynolds et al., 2006; Schofield et al., 2007;
Martinez-Avila et al., 2009) can be thiolated for attachment to
AuNPs via ligand exchange. These nanoparticles may be useful as
sensitive colorimetric probes for a variety of metal ions. Mannose
and lactose have also been used for the reduction of gold salts
and stabilization of the nanoparticles. Schofield et al. have shown
that thiolated carbohydrate derivatives can be readily assembled
on silver and gold NPs. These metal glycoNPs can be used to
develop aggregation based colorimetric bioassays (Schofield et al.,
2006).
Magnetic glycoNPs with unique properties have also been
reported, although in a more limited number (El-Boubbou and
Huang, 2011; Marradi et al., 2013). Once carbohydrates are
attached on theMNPs, it is crucial that they retain their biological
activity. To explore this, plant lectins can be used, as their interac-
tion with carbohydrates is highly selective. The clustering of the
MNPs due to the selective recognition of the lectin can be detected
using MRS assays (Moros et al., 2010).
Carbohydrates can also be used to target different cells and/or
enhance the cellular uptake of NPs in a highly specific way. For
instance, Moros et al. functionalized MNPs with glucose and
galactose using EDC and studied their interaction with Vero cells
in vitro (Moros et al., 2012). Although these monosaccharides
share the same chemical formula, except for the spatial conforma-
tion of the hydroxyl group in C-4, the cell entrance pattern was
completely different. While MNPs-glucose entered all through-
out the cell, MNPs-galactose remained predominantly in the cell
periphery. By preparing a library of MNPs functionalized with
different monosaccharides, El-Boubbou et al. were also able to
detect, differentiate cancer cells and quantitatively profile their
carbohydrate binding abilities by MRI (El-Boubbou et al., 2010).
Carbohydrates have been also conjugated to QDs (Chen et al.,
2003; Osaki et al., 2004; Kikkeri et al., 2009; Cai et al., 2012; Yang
et al., 2012a). For example, Kikkeri et al. synthesized PEGylated
QDs capped with D-mannose, D-galactose, and D-galactosamine
to study specific carbohydrate-protein interactions in vitro and
in vivo. These QD-carbohydrates were produced through covalent
coupling by 4-maleimidopropanoic acid NHS ester and used for
in vitro imaging and in vivo liver targeting (Kikkeri et al., 2009).
Shinchi et al. also developed glycol-QDs by preparing stable
sugar-chain-immobilized fluorescent nanoparticles (CdTe/CdS
core/shell QDs functionalized with sugar-chain-ligand conju-
gates, β-galactose- and α-glucose) and their application to the
analysis of sugar-chain-protein interactions and cellular imaging
(Shinchi et al., 2012).
BIOMOLECULE COUPLING STRATEGIES
Functionalization of NPs with biomolecules has to face several
hurdles and surface modifications can have significant impacts
on their physical-chemical properties and therapeutic efficacy,
once they might alter surface charge, size, hydrophobicity, and
targeting skills. One of the biggest challenges is that NPs need
to remain stable in solution while the conjugation takes place.
However, many NPs may precipitate while being activated, as
their stability depends on a delicate balance between attractive
and repulsive forces, which can be modified when using differ-
ent chemicals for their biofunctionalization. Moreover, due to
the huge amount of different NPs and biomolecules reported
so far, there are no standardized protocols for NP functionaliza-
tion. Therefore, the choice of a coupling strategy depends on the
Frontiers in Chemistry | Chemical Engineering July 2014 | Volume 2 | Article 48 | 12
Conde et al. Biofunctionalization and surface chemistry of inorganic nanoparticles
FIGURE 7 | Gold glyconanoparticles. (A) Strategy for studying
carbohydrate ± carbohydrate interactions based on 2D and 3D models that
mimic carbohydrate presentation at the cell surface. Preparation of
(B) glyconanoparticles; (C) hybrid glyconanoparticles; (D) fluorescence
glyconanoparticles (Barrientos et al., 2003). Reproduced with permission
from Barrientos et al. (2003), Copyright 2013.
stability of the NP, the functional groups, the bioconjugation con-
ditions (pH, temperature, ionic strength, solvent choice, structure
of the surfactant) and the biomolecule to attach, among others.
Finally, depending on the conjugated biomolecule, it is important
to control the orientation, so that the biomolecule remains active
once conjugated to the NP.
Biofunctionalization can be achieved using several techniques,
such as physical adsorption and electrostatic binding, specific
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affinity recognition, and covalent coupling, each of which has its
own advantages and disadvantages. In this section of the review,
the several coupling strategies for biofunctionalization of gold,
MNPs and QDs will be examined.
Covalent strategies
Covalent coupling provides stable and strong binding of the
biomolecules to the NPs. Most proteins have amine groups in
their surface, so they can be directly conjugated to NPs contain-
ing reactive groups such as aldehydes, epoxides or anhydrides
(Fuentes et al., 2005; Lu et al., 2008).
On the other hand, coupling of NPs that exhibit amine groups
with molecules containing aldehydes or epoxides can also be
used. However, some biomolecules such as antibodies, oligonu-
cleotides, carbohydrates or peptides do not include these func-
tional groups, and should be modified prior to the conjugation
(Nobs et al., 2004). For instance, carbohydrates present in some
antibodies can be oxidized using periodate to generate aldehyde
groups that can react with the amino groups present on the NPs
surface (Fuentes et al., 2005). Nevertheless, chemical modifica-
tion may compromise biomolecules’ activity, so one of the most
frequent ways to conjugate molecules to the NPs is using linker
molecules.
EDC coupling reaction. 1-Ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) is a zero-length crosslinking agent used to
couple carboxyl or phosphate groups to primary amines, which
may react with a carboxyl group of a biomolecule, forming an
amine-reactive O-acylisourea intermediate. Addition of sulfo-
NHS stabilizes the amine-reactive intermediate by converting it
to an amine-reactive sulfo-NHS ester. The O-acylisourea inter-
mediate may also react with an amine on a second biomolecule,
producing a conjugate of the two biomolecules joined by a stable
amide bond. This crosslinker has been used in diverse appli-
cations, such as conjugation of carboxyl to amine groups in
peptides and proteins, forming amide bonds in peptide synthe-
sis, attaching haptens to carrier proteins and form immunogens,
labeling nucleic acids through 5′ phosphate groups and creat-
ing amine-reactive NHS-esters of biomolecules (Grabarek and
Gergely, 1990).
One of the main advantages of EDC coupling is water solu-
bility, which allows direct bioconjugation without prior organic
solvent dissolution. On top of that, the excess of reagents and
by-products can be easily removed by dialysis or gel-filtration
(Sheehan et al., 1965). However, the coupling reaction has to
be carried out fast, as the reactive ester that is formed can be
rapidly hydrolyzed in aqueous solutions. To increase the sta-
bility of this active ester, N-hydroxysuccinimide (NHS) or N-
hydroxysulfoxuccinimide (sulfo-NHS) can be used (Jang and
Keng, 2008). Key parameters that should be controlled when
using EDC are pH (as hydrolysis is largely dependent on pH), the
amount of EDC so that NPs do not aggregate due to loss of elec-
trostatic repulsive forces between NPs, and the ratio EDC/NHS
(Nakajima and Ikada, 1995; Sam et al., 2009; Shen et al., 2009).
Using this protocol almost all kinds of molecules (i.e.,
enzymes, antibodies, peptides, DNA, fluorophores, etc.) may be
attached to the nanoparticle surface without prior modification
FIGURE 8 | EDC coupling reaction. The 1-ethyl-3-(3-dimethylaminopropyl)-
carbodiimide (EDC) is a zero-length crosslinking agent used to couple
carboxyl groups to primary amines. In the presence of
N-hydroxysulfosuccinimide (Sulfo-NHS), EDC can be used to convert
carboxyl groups to amine-reactive Sulfo-NHS esters. The addition of
Sulfo-NHS stabilizes the amine-reactive intermediate by converting it to an
amine-reactive Sulfo-NHS ester, thus increasing the efficiency of
EDC-mediated coupling reactions. Excess reagent and crosslinking by
products are easily removed by washing with water. Once EDC is water
soluble, the crosslinking can be done under physiologic conditions without
adding organic solvent.
(see Figure 8) (Pandey et al., 2007; Susumu et al., 2007; Rostro-
Kohanloo et al., 2009; Conde et al., 2012a; Lavilla et al., 2012).
For instance, using the EDC chemistry, Weissleder and coworkers
created a library of MNPs decorated with different synthetic small
molecules for the development of magnetofluorescent reporters
(Weissleder et al., 2005). Using these fluorescent MNPs it was
possible to screen against different cell types or among differ-
ent physiological states of a cell line. On the other hand, Sanz
et al. have reported the effect of biofunctional spacers, such as
thiolated PEG chains on the loading of RNA molecules and a
positive peptide functionalized by EDC coupling reactions on
the surface of AuNPs (Sanz et al., 2012). Lin and coworkers also
used EDC to attach CH3O-PEG-NH2 to different types of car-
boxylated NPs (MNPs, QDs) demonstrating that adjusting the
ratio EDC/NP it was possible to prepare NPs with 0, 1, or 2
attached PEG molecules (Lin et al., 2008). Similarly, Parak and
co-workers also used EDC to attach NH2–PEG–NH2 molecules,
varying the molecular weight of the polymer on the surface
of AuNPs (Sperling et al., 2006; Pellegrino et al., 2007). The
covalent attaching of biofunctional short PEG molecules to the
polymer shell produces very stable particles in electrolytic solu-
tion. This approach results in stable water-soluble AuNPs (Sanz
et al., 2012) and QDs (Ballou et al., 2004) with functional groups,
e.g. −COOH or −NH2 on the free ends of PEG molecules.
By controlling the EDC ratio, aggregation was prevented. Dhar
et al. have exploited the rapid intracellular uptake of AuNPs to
deliver and activate cisplatin and achieve efficient cytosolic deliv-
ery of platinum(IV) prodrug to lung cancer cells. The AuNPs
used in this study were functionalized with thiolated oligonu-
cleotides containing a terminal dodecyl amine for conjugation
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with a platinum(IV) compound capable of being tethered to
an amine functionalized DNA-AuNP surface via amide linkages
(Dhar et al., 2009).
Similarly, conjugation of biomolecules to QDs through cou-
pling reactions with reactive functional groups presented on QDs
surface is another common strategy to prepare QD bioconjugates.
Actually, carboxylic acid groups can also be added to QDs’ sur-
face and subsequently conjugated to biomolecules with primary
amine groups through EDC coupling reactions (Cai et al., 2006;
Hua et al., 2006; Choi et al., 2009; Wu et al., 2009a; East et al.,
2011).
One disadvantage of this type of chemistry is that the pres-
ence of both carboxylates and amines on one of the biomolecules
to be conjugated with EDC can result in self-polymerization and
consequently, loss of effectiveness. For instance, peptides usually
contain both types of groups, so if EDC is added in the pres-
ence of them, peptides can polymerize. However, Bartczak et al.
have used this strategy to coupling of peptides to AuNPs in a one-
pot way. The authors have shown that the concentration, reaction
time, and chemical environment are all critical to achieving the
formation of robust, peptide-coated colloidal nanoparticles with-
out aggregation (Bartczak and Kanaras, 2011). Another way to
avoid polymerization of the biomolecule is to eliminate the excess
of EDC before adding the biomolecule to the NPs solution by
magnetic separation in the case of MNPs or gel-filtration for
other NPs.
Despite the simplicity of this technique, that does not require
prior chemical modification of the biomolecule, it does not guar-
antee an oriented immobilization in the case of biomolecules
with greater structural complexity, such as antibodies. Due to the
poor stability of the reactive ester, neutral pH is traditionally used
to link covalently antibodies to carboxylated-NPs. At this pH,
immobilization mainly occurs through direct covalent binding of
the most reactive amine groups of the antibody. Unfortunately,
these are the terminal amine moieties of the four Ab polypeptide
chains (pKa around 7–8), which are all located in the antigen-
binding domain (Puertas et al., 2011). Recently, Puertas et al.
described a smart approach that takes advantage of the exist-
ing kinetic differences among ionic adsorption processes and
covalent reactions in order to assure the oriented covalent attach-
ment of the Ab using EDC chemistry. Briefly, it requires the
selection of the best incubations conditions (pH, ionic strength)
to promote a fast ionic adsorption of the Ab due to the neg-
ative charges of the carboxylic groups of the NP. This ionic
adsorption makes possible the orientation of the Ab on the NP
surface before irreversible covalent bond formation (Figure 9)
(Puertas et al., 2011). Initially, the authors optimized this two-
step strategy for magnetic NPs but they have recently extended
FIGURE 9 | Highly active magnetic nanoparticle-antibody conjugates.
(A) Two-step immobilization mechanism proposed when using Ab that bind to
the MNPs through the most reactive amines—random immobilization.
(B) Covalent attachment via the polysaccharide moieties of the antibody to the
MNPs—oriented immobilization. (C) Capacity to capture HRP of the anti-HRP
anchored to MNPs by different orientations. The protein content of all
anti-HRP-functionalizedMNPswas similar (2μgAbpermgMNP) (Puertas et al.,
2011). Reproduced with permission from Puertas et al. (2011), Copyright 2013.
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FIGURE 10 | Maleimide coupling reaction. Maleimide reacts with free
sulfhydryl group(s), forming stable thioether linkages, at physiological pH. It
is useful for bioconjugation of proteins with −SH groups and the coupling
of two thiols to form a disulfide linkage.
application for functionalization of other nanostructured materi-
als, such as gold nanoprisms and carbon nanotubes (Polo et al.,
2013).
Maleimide coupling. Maleimide can be used to conjugate
primary amines to thiols (Brinkley, 1992) (see Figure 10).
The use of maleimide for modification of sulfhydryl groups
has been extensively described in the literature (Means and
Feeney, 1990). Reaction with sulfhydryl groups generates a sta-
ble 3-thiosuccinimidyl ether linkage and occurs normally at
pH 6.5–7.5. One of the main limitations is that the maleimide
ring may hydrolyze in aqueous buffer to a non-reactive cis-
maleamic acid derivative over long reaction times or at pH >
8.0. Nevertheless, this type of conjugation shows a lot of poten-
tial for a great number of biomolecules that bear reactive thiol
or amino groups. This may eventually lead to non-specific bonds
and crosslinking between functionalized nanoparticles since a
single biomolecule may have several thiol groups (Means and
Feeney, 1990; Brinkley, 1992).
Maleimide coupling has been used to conjugate several
biomolecules to AuNPs, such as peptides (Oh et al., 2010a; Ravi
et al., 2012), chemotherapeutic agents (Hwu et al., 2009), dyes
(Zhu et al., 2012a), and DNA (Lee, 2011). In fact, Ba et al.
presented a versatile and controlled route to immobilize AuNPs
on the surface of living cells, while preserving the sensing and
optothermal capabilities of the original colloid, by chemically
anchoring the nanoparticles to phospholipids in liposomes via
maleimide-thiol reactivity (Ba et al., 2010).
Maleimide coupling was also used to couple DNA (Dubertret
et al., 2002), PNAs (Srinivasan et al., 2006), proteins (Wolcott
et al., 2006; Bonasio et al., 2007; Zhou et al., 2007), and antibodies
into QDs (Diagaradjane et al., 2008). To address biocompat-
ibility issues of QDs, Dubertret et al. encapsulated individual
nanocrystals in phospholipid block-copolymer micelles conju-
gated to DNA and demonstrated their function as fluorescent
probes (Dubertret et al., 2002). Bonasio et al. also reported the
specific and covalent labeling of QDs with a membrane protein
and organic fluorophores (Bonasio et al., 2007).
Similarly, MNPs can also be functionalized using the
maleimide coupling reaction with PEG (Kuhn et al., 2006), DNA
(Nam et al., 2004) or even drugs, such as chlorotoxin (Kievit
et al., 2010). Concerning antibodies, this chemistry could be
also used with thiol or amino groups on the nanoparticle sur-
face (Lee et al., 2007; Haun et al., 2010). Regarding a thiolated
NP, antibodies would bind through their most reactive amine
groups and, as previously explained, this could lead to a ran-
dom orientation with partial loss of the Ab’s biological activity.
Instead, maleimide chemistry used with aminated NPs ensures
an oriented binding through thiol groups of the Ab. However,
as in Abs sulfhydryls are oxidized as disulfides. So it is neces-
sary to selectively reduce the disulfides at the hinge region by a
reducing agent (i.e., 2-mercapthoethylamine, mercaptoethanol,
dithiotreitol, thiopropyl-agarose). This chemical modification
can also be combined with fragmentation of the IgG by the use
of proteolytic enzymes (i.e., pepsine, ficin) in order to conjugate
small Ab fragments such as F(ab′)2 and Fab′.
Click-chemistry reaction. The copper(I)-catalyzed azide-alkyne
cycloaddition (CuAAC) click reaction has been recognized as
a facile and versatile chemistry for bioconjugation. Azides and
alkynes are highly energetic functional groups with particularly
narrow distributions of reactivity. Thanks to their weak acid-base
properties, they are nearly inert toward biological molecules and
toward the reaction conditions found inside living cells. The azide
groups are easy to introduce into organic compounds by both
nucleophilic and electrophilic processes. One of the most com-
mon bioconjugation of azides is the copper catalyzed azide-alkyne
cycloaddition (CuAAC) (Wang et al., 2003) (see Figure 11). This
reaction features an enormous rate acceleration of 107–108 com-
pared to the uncatalyzed 1,3-dipolar cycloaddition (Himo et al.,
2005). This reaction has also been termed the “cream of the crop”
of click reactions and is surely responsible for the tremendous
popularity of the “click” concept andmany simply associate “click
chemistry” to mean triazole formation between an azide and
alkyne. The reaction occurs at room temperature, showing a high
degree of solvent and pH insensitivity, and high chemoselectivity
(the azide and alkyne are inert to react with numerous functional
groups under the typically mild reaction conditions). In fact, the
reaction succeeds over a broad temperature range, is insensitive
to aqueous conditions and occurs in a pH range between 4 and
12 (Hein and Fokin, 2010; Le et al., 2010). The copper catalyzed
azide-alkyne cycloaddition occurs between an organic azide and
a terminal acetylene. The cyclic product is a triazole. The copper
catalyst allows the reaction to proceed at room temperature and
confers regioselectivity (a reaction in which one direction of bond
making or breaking occurs preferentially over all other possible
directions), with the 1,4 regioisomer being the only product. The
reaction start by the incubation with a mixture of copper(II) (e.g.
copper(II) sulfate) and a reducing agent (e.g. sodium ascorbate)
to produce Cu(I) in situ (Meldal and Tornoe, 2008; Hong et al.,
2009).
Click chemistry sometimes refers to a group of reactions that
are fast, simple to use, easy to purify, versatile, regiospecific,
and give high product yields. However, the click reaction has a
number of limitations. First, like with any cycloaddition, if the
azide group is too electron deficient, then it will not undergo
the reaction. In other words, the ground state configuration
of the azide is far too low to interact with the terminal alkyne
(Hein et al., 2008). Secondly, a more common problem is alkyne
homocoupling. This phenomenon occurs when an alkyne reacts
with a second alkyne instead of the azide. This process can be
minimized by using a sterically bulky base that stabilizes the
reactive intermediates of the homocoupling reactions. The Cu(I)
saturation is rare but can also be a problem, once the alkynes may
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FIGURE 11 | Click chemistry reaction. The copper-catalyzed cycloaddition
of azides and alkynes (CuAAC) developed for click chemistry joins an
organic azide (N3) and alkyne together producing a mixture of 1,4- and
1,5-triazoles.
chelate the Cu(I)-acetylide complex intermediate that contact
with the azide group (Hein et al., 2008). Besides these limitations,
one of the most obvious disadvantages is the requirement of a
copper catalyst. In fact, an excessive intake of copper can lead
to drastic consequences for the human body (e.g. hepatitis,
neurological disorders, kidney diseases and Alzheimer’s disease)
(Wang and Guo, 2006; Hein et al., 2008).
Generally, the click-chemistry reaction has been used to couple
AuNPs to proteins (Zhu et al., 2012b), enzymes (Brennan et al.,
2006; Kim et al., 2010), fluorophores (Voliani et al., 2011), poly-
mers (Boisselier et al., 2008; Zhang et al., 2009), and other small
molecules (Fleming et al., 2006). For example, following click-
chemistry reaction Fleming et al. were able to conjugate to AuNPs
several different alkyne derivatives, such as ferrocene, aniline and
PEG (Fleming et al., 2006).
Alkyne-functionalized AuNPs have been also extensively used
to detect metal ions in aqueous solutions, such as Cu2+, using
click chemistry. This method allows visualization by naked eye of
the presence of Cu2+ ions by the aggregation of AuNPs as a result
of the Cu(I)-catalyzed conjugation between the two functional
groups (Zhou et al., 2008b; Xu et al., 2010; Lin et al., 2012).
Another common type of nanoparticles used for click-
chemistry bioconjugation is QDs. QDs need to be coated to other
chemical species if they are to be used as biomarkers, thera-
peutic agents or sensors. In fact, water soluble and water QDs
have been successfully coated with polymers via click-chemistry
reactions (Beaune et al., 2011; Janczewski et al., 2011; Lai and
Guan, 2011; Petryayeva and Krull, 2012; Zhang et al., 2012a).
Jan´czewski et al. reported the use of click-QDs by producing water
solubilization of hydrophobic CdSe/ZnS QDs using amphiphilic
polymeric coatings. The authors described the preparation of
acetylene- and azide-functionalized QDs for “click” chemistry.
The method is universal and applicable to any type of nanoparti-
cle stabilized with hydrophobic ligands able to interact (in water)
with the alkyl chains present in the coating (Janczewski et al.,
2011).
Interestingly, Hao et al. reported a method for labeling viruses
via copper-free click chemistry to QDs. The authors linked virions
modified with azide to QDs capable of realizing single-virion
tracking, laying the foundation for long-term dynamic visualiza-
tion of virus infection process (Hao et al., 2012).
Although click chemistry does not appear to be a major type
of chemistry for MNPs, some interesting examples can be found
in the literature. For instance, Santra and coworkers reported
the creation of novel polymeric-metallic nanocomposites when
assembling alkylated IONPs with azide polymer fluorescent NPs,
obtaining a fluorescence material with enhanced magnetic prop-
erties for MRI (Santra et al., 2009). The first example of click
MNPs for in vivo applications was reported by Bhatia and cowork-
ers (von Maltzahn et al., 2008). Fluorescent MNPs functionalized
with a tumor-targeting peptide (Lyp-1) via click chemistry were
able to stably navigate the systemic circulation, extravasate into
tumors and penetrate into the interstitial space to specifically
bind to receptors on tumor cells. Weisledder group also reported
the introduction of 18F onto azide-modified MNPs using click-
chemistry for in vivo PET imaging (Devaraj et al., 2009).
Non-covalent strategies: physical interactions
Physical interactions include electrostatic, hydrophobic and affin-
ity interactions. These interactions have several advantages, such
as the ease of functionalization, speed of binding and that neither
the biomolecules nor the NPs must be modified in case of elec-
trostatic and hydrophobic interactions. However, conjugation is
less stable and reproducible when compared to covalent methods.
Moreover, it is difficult to control the amount and orientation of
bound molecules.
Ionic coupling. Ionic adsorption provides a simple and straight-
forward method to functionalize NPs with biomolecules. In fact,
biological and polymeric species with an opposite charge can be
coupled to NPs (Conde et al., 2012a) or between different oppo-
site charged NPs (Liu et al., 2012). Ionic binding rate mainly
depends on the amount of charges present on the NPs and the
biomolecules, as the binding is made by multiple point (multi-
punctual). Therefore, when binding complex molecules such as
antibodies or proteins, the isoelectric point should be considered,
as their net charge would depend on it.
Ionic coupling has been traditionally used to adsorb proteins
to NPs (Brewer et al., 2005; Hong et al., 2006; Reed and Metallo,
2010; Guo et al., 2011; Brancolini et al., 2012; Strozyk et al.,
2012), as some proteins such as serum albumin can stabilize
NPs by preventing aggregation (Brewer et al., 2005). Moreover,
proteins can be adsorbed to NPs to increase cellular uptake or
specificity toward tumor cells (Chang et al., 2012). Negatively
charged hyaluronic acid (HA) was also used to self-assemble onto
the positively charged QDs through ionic interactions. For this,
Bhang et al. developed a simple and novel electrostatic coupling
method, which provides a HA-QD conjugate with cancer tar-
geting efficiency to use in diagnostic and imaging applications.
These conjugates were also effective for fluorescence staining of
lymphatic vessels in vitro and in vivo (Bhang et al., 2009).
Despite the ease of this conjugation method, the native struc-
ture of the adsorbed proteins may be affected (Lacerda et al.,
2010), which could ultimately result in loss of biological activity
or even cellular toxicity (Vertegel et al., 2004; Deng et al., 2011).
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FIGURE 12 | Ionic coupling. Coupling of negatively charged siRNA (left)
and of positively charged proteins (right) to negatively or positively charged
AuNPs.
Other examples of biological applications are the coupling of
negatively charged DNA (Thomas and Klibanov, 2003; Ghosh
et al., 2008; Conde et al., 2012b) or siRNA (Elbakry et al., 2009;
Guo et al., 2010; Conde et al., 2012a; Zhao et al., 2012a) to pos-
itively charged NPs (Figure 12) (Huschka et al., 2012). In fact,
Conde et al. reported functionalization of siRNA by ionic cou-
pling to a positively charged layer formed by quaternary ammo-
nium groups (R4N+). Ionic interactions between the negatively
charged siRNA backbone (via phosphate groups) and quaternary
ammonium positively charged groups ensured binding of siRNA
onto the AuNPs’ surface for the whole pH range. Using a hier-
archical approach including three biological systems of increasing
complexity, in vitro cultured human cells, in vivo freshwater polyp
(Hydra vulgaris) and in vivo healthy mice model, these authors
identified the most adequate nanoparticles to efficiently transport
siRNAs. The results evidenced the importance of a correct design
in the functionalization of nanoparticles for biological applica-
tions, in particular for complex animal systems, such as mice. The
ionic linkage of siRNA on the AuNPs showed efficiency in cells
and in Hydra. However, only a covalent bond ensured an active
and efficient RNAi mechanism in mice (Conde et al., 2012a).
Similarly, Li et al. reported the development of QDs-DNA com-
plexes that are disrupted and DNA released by glutathione (GSH)
at intracellular concentrations (Li et al., 2008).
As extensively reviewed by others (Montenegro et al., 2013),
conjugation of Abs to NPs may be made with covalent immo-
bilization techniques such as those mentioned before, but also
with non-covalent strategies. The most common technique is the
electrostatic adsorption of Abs by charge interaction to opposite
charged NPs. This ionic adsorption is directly related to the Abs
isoelectric point, pH at which they are neutral. Since it depends
mainly on the number of charged groups, the Abs immobilized
region will be where the greatest number of charges are present
(Jung et al., 2008). This method, although of easy implementa-
tion, shows several disadvantages. The main concern is the weak
pH dependent interaction between the Ab and NP. Any changes
to the pH and/or ionic strength may incur in desorption of the
Abs molecules. Additionally, the heterogeneous charge distribu-
tion and the unexploited charged groups of the Abs can promote
non-specific adsorption to matrix proteins, for example compet-
itive displacement caused by serum proteins (van der Voort et al.,
2004; Murcia and Naumann, 2005).
Hydrophobic coupling. Hydrophobic interactions have been
widely exploited to attach lipophilic drugs to NPs, from where
FIGURE 13 | Hydrophobic coupling. Use of amphiphilic polymers as
nanoparticle and drug delivery moieties.
the drug might be released once inside the cells (Wahajuddin and
Arora, 2012). For instance, docetaxel has been easily adsorbed to
the oleic acid layer that surrounded hydrophobic MNPs prior to
their encapsulation in a polymeric vesicle, providing a controlled
drug release profile for a month (Ling et al., 2011). Encapsulation
of drugs can also be done adsorbing them to hydrophobic poly-
mers or cyclodextrins for instance (Yallapu et al., 2011) (see
Figure 13).
Similarly, hydrophobic molecules such as fluorophores can
be coupled to NPs. Foy and coworkers coated hydrophobic NPs
with amphiphilic polymers, to which they adsorbed five different
dyes to determine MNP biodistribution using a mouse xenograft
breast tumor model (Foy et al., 2010). Moreover, Kim et al.
developed AuNPs functionalized with water-soluble zwitterionic
ligands from kinetically stable complexes with hydrophobic drugs
and dyes, which are efficiently released into cells (Kim et al.,
2009). This coupling method minimizes changes to the surface
and allows the creation of NP with dual properties, such as optical
and therapeutic, in an easy way.
Proteins and Abs can also be adsorbed to NPs via hydropho-
bic interactions. However, they often suffer from denaturation,
leading to poor reproducibility. Hydrophobic interactions with
the hydrophobic surfaces of proteins or Abs force a change in
the native structure because of exposure of its inner region,
which could ultimately results in loss of activity (Zuo et al., 2010;
Shemetov et al., 2012). Moreover, regarding ionic binding, con-
trolling the orientation or the amount of bound molecules is
difficult to achieve.
Biotin-avidin system. For NPs conjugation, factors such as solu-
bility, charge and all the aforementioned functional groups confer
the biotin a relevant importance (Aslan et al., 2004). Biotinylation
of NPs and biological molecules nowadays is fairly common
as biotin can be synthesized to have a distal amine, thiol, car-
boxyl and other functional groups, simplifying the conjugation
(Hermanson, 2008). However, to avoid a random immobiliza-
tion of structural complex biomolecules such as proteins, it is
compulsory to achieve a site specific biotinilation. Concerning
antibodies, for example, biotinilation must be carried out within
its Fc region via the carbohydrates moieties or via thiols obtained
after reduction of the disulfides located in the hinge region (Cho
et al., 2007).
Genetic engineering has also improved biotinylation by
recombinantly introducing biotin labeling sites into fusion pro-
teins (Cronan, 1990; Cull and Schatz, 2000). Nowadays several
companies offer biomolecules and NPs modified with biotin or
avidin species. The high-affinity of the avidin-biotin interaction
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FIGURE 14 | Biotin-avidin system. Schematic of inhibition assay method
based on the photoluminescence quenching of SA-QDs by Biotin-AuNPs.
SA denotes the streptavidin immobilized on the surface of QDs, and Av is
the externally added avidin (Feng et al., 2013). Reproduced with permission
from Feng et al. (2013), Copyright 2013.
(Kd around 10−14) has made it perfect for the development of
NPs-based biosensors. The main method of bioconjugation using
avidin-biotin chemistry comprises the functionalization of NPs
with avidin, for later incubation with a biotinylated molecule.
Since avidin and its variants are zwitterionic molecules, they
can be subject to electrostatic adsorption to negatively charged
nanoparticles (see section Non-Covalent Strategies: Physical
Interactions). The vast number of publications that apply biotin-
avidin interaction for bioconjugation shows the importance of
this strategy. Recently, Feng et al. showed that DNA detec-
tion could be improved using streptavidin coated AuNPs (Feng
et al., 2013). Another interesting strategy was reported by Oh
et al. where by modulating the FRET efficiency between QDs
and AuNPs they were able to detect molecules which inhibited
the interaction between streptavidin and biotin (Figure 14) (Oh
et al., 2005). By capping the AuNPs with polyamidoamine den-
drimers, the biotinylation was possible using sulfo-NHS-biotin.
A similar strategy was employed in the biotinylation of MNPs.
To achieve aMNPs-PEG-biotin conjugate the NPs were incubated
with a phospholipid-PEG-biotin construct. By coupling DC14:0
PE (dimyristoylphosphatidylethanolamine) to further activate
α-biotinylamido-ω-N-hydroxy-succinimidcarbonyl-PEG, the
authors could produce MNPs covered with PEG-biotin. The
functionalization was confirmed when binding streptavidin
alkaline phosphatase the complexes became highly aggregated
(Hodenius et al., 2012).
The strong association between avidin and biotin has made
this system a reference for the development and troubleshoot-
ing of NPs-based biosensors. It is also a crutch for conjugation
of other biomolecules onto the surface of NPs. However, it is
important to note that avidin is a glycoprotein with a high iso-
electric point (∼10). This could cause the unspecific binding of
other compounds present in complex biological samples. To over-
come this problem, it is preferred the use of streptavidin. As it is
purified from a bacteria (Streptomyces avidinii) is not a glycopro-
tein and has much lower isoelectric point (around 5–6). Besides,
the tetrameric nature of each (strept) avidin molecule becomes a
problemwhen control of the Ab stoichiometry is needed. To over-
take this problem, it is possible to use recombinant monomerics
forms of these proteins but taking into account that the affin-
ity for biotin would be much lower (around 10−7 M) (Wu et al.,
2009b).
CONCLUSIONS AND FUTURE PERSPECTIVES
In the near future, it is expected that the design of nanosystems
will revolutionize the medical healthcare field by their application
in the development of ultrasensitive and multiplexed diagnostic
systems, targeted and remotely controlled drug delivery systems
for treatment of diseases, in vivo imaging, tissue/organ regenera-
tion and gene therapy solutions. The last three decades have been
an exciting period in the synthesis of inorganic nanoparticles with
interesting intrinsic properties for their use in such applications.
Indeed, many of these synthetic processes have not only demon-
strated proof-of-concept feasibility but progressed to full-scale
commercial production. However, optimization of appropriate
size scale and batch-to-batch reproducible synthetic procedures of
NPs with unique optical or magnetic properties is not sufficient
to ensure biomedical application. For this, functionalization of
the NPs with biomolecules is crucial in order to impart biological
recognition and interaction skills.
Selecting the most adequate biofunctionalization strategy is no
mean feat, since no universal methodologies exist to cover the
wide variety of inorganic nanoparticles and biomolecules avail-
able for this purpose. A functionalization protocol that works well
for one type of NP may not work for another, since they could
be very different in terms of size, charge, surface area, colloidal
stability, density and type of reactive groups, etc. Furthermore,
biomolecules vary significantly in terms of size, chemical compo-
sition, 3D complexity and location of its biological active site. As
discussed along this review, in absence of standard functionaliza-
tion protocols, each particular case (nanoparticle + biomolecule)
requires optimization. Thus, in addition to the development of
“smart” multifunctionalization strategies, it is vital to focus on
the synthesis of “smart” nanoparticles over the next decade. These
NPs should be able to deliver a therapeutic agent based on envi-
ronmental causes or remote stimulus and with the capability to
temporarily adapt their size, shape, surface chemistry, wettabil-
ity and adhesive properties to surrounding environments. These
long-term goals would allow an overall impact on the medical
field with significant advances in patient screening, monitoring,
diagnosis, staging, and treatment.
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